19 - 20 November 2015 | Philadelphia, PA
At eyeforpharma's 3rd annual Customer Engagement Summit delegates will learn how to engage their key customers through a wide range of channels – from digital to F2F. More info here...

Wednesday, May 27, 2009

"New" Nalts Video Resurfaces: "Enlightened Stupid Marketer"

Kevin Nalts (aka Kevin Nalty, former Merck Marketing Director), self-proclaimed YouTube comedian and "viral video genius," revealed to me a video piece he did about a year ago that remained private (restricted access) until just recently.

The video, entitled "Enlightened Stupid Marketer," was "inspired by some comments from someone that spoke at a Florida conference, but some of my colleagues took offense of it," said Nalts.

In his video notes, Nalts says "This educational video helps you understand the mind of a marketer, and what shapes our decision making, workplace behavior and marketing mix. Can you become a marketer, or are they born? Find the answer you've long sought."

"A non-marketer might be looking at this and saying, 'Stupid Marketer...isn't that an oxymoron," says Nalts in the video.

"I say no, because there are stupid marketers and there are enlightened stupid marketers. Enlightened stupid marketers are at a fork in the road. Keep being stupid or be stupid but conceal that fact. I have several proven strategies for this." He then goes on to share those strategies, which are hilarious. You might just be a enlightened stupid marketer if you employ one or more of these strategies.

Here's the video:

Some of the 274 comments to this video (made a year ago, before the video was pulled) include:
"I too am an enlightened stupid marketer- and this seriously made my day- because I work with way too many people who say and do these things all the time!"

"ooh.. i am getting my business management degree in 3 months.. you discourage me from being a marketer "

"nalts.. your job wears you down.. you need a psychiatrist. damn. marketers are dumb.. all theory and shit.. too much theory "

"Something akin to cultivating ubiquitous methodologies with relation to extending interactive portals - so to speak, scaling killer convergence while proactively seizing viral markets and, with all things being equal, generating revolutionary mindshare. Five out of five!"

"A traveling salesman can always say, "At least I didn't have to live my life in the dreary shadows and quiet desperation of 'marketing' and of attending meetings with 'enlightened' marketeers speaking with the voice of the customer to drive customer value to the dashboard of executive insight.""

"Nalts, my friend, you have the Wallenda Factor of Powerful punditry for growing the product with your ideas of solid benchmarking to achieve best practices. Your core competences will declutter the bottom line."
Nalts will be featured in the upcoming May 2009 issue of Pharma Marketing News. Subscribe today and get it FREE!

Nalts is the John Cleese of Marketing!
Nalts is on his way to becoming the John Cleese (former member of Monty Python's Flying Circus) of marketing. I see his career as a motivational marketing speaker blossoming. He should be hired by Merck and J&J and every other big pharma company to come in and give marketing teams a dose of reality via humor, just like John Cleese does in his business training videos!

P.S. This Just In! Kevin Nalty Appointed Chief Strategy Officer, HITVIEWS

HITVIEWS, the first company to recognize the power of online WebStars to generate positive business results for brands, signs Kevin Nalty as its Chief Strategy Officer. He will be responsible for continuing HITVIEWS' aggressive entry into the marketplace. Sales tactics, marketing rollouts, public relations and industry relations will be his responsibility. More...

1 comment:

  1. Hi John,
    Interesting and mixed views wrt Marketing in general. Though the truth remains that despite the cliched use of Marketing as a term, its application is still in a nascent stage, particularly for the Pharmaceutical Industry.

    Not so much for the Innovator drugs where the innovation/drug discovery itself partially takes care of the Marketing part - but imagine the requirements of marketing a Biogenerics/Biosimilars to the consumers (esp if the INN rule applies as is currently in EU).
    Its such an unexplored field - what do you market your drug as?? How do you position it??

    Would be interesting to have your thoughts on the same in any of your future posts!!


Related Posts Plugin for WordPress, Blogger...